Medicen Paris Region (Greater Paris) and BioWin (Walloon region), two of Europe’s leading health innovation
competitiveness clusters, today announce their unique partnership, offering crossmembership to their affiliates
Since 2015, Medicen and BioWin have worked together to bring their ecosystems closer by organizing joint events and connecting members. The clusters share international ambitions and strategic priorities. Signing this agreement shows their willingness to strengthen European competitiveness in health innovation.
Organizations subscribing to this cross-membership will benefit from a 50% discount on Medicen membership fees and vice versa. They will also get access to members of both ecosystems, support for collaborative R&D projects as well as counsel on best financing options. Several members of both clusters are well-known at a European level for their excellence, both in clinical research (AP-HP, Institut Jules Bordet) and in industrial production of innovative therapeutic solutions (Baxter, Microsoft, GSK, Sanofi and others).